2010 Vanderbilt Prize awarded to Duke University researcher

October 29, 2010

Nancy Andrews, M.D., Ph.D., a groundbreaking researcher and the first woman dean of Duke University School of Medicine, has been awarded the 2010 Vanderbilt Prize in Biomedical Science.

The prize, established by Vanderbilt University School of Medicine in 2006, honors nationally known women scientists who have "a stellar record of research accomplishments" and who have contributed significantly to the mentorship of other women in science.

Andrews, who also is vice chancellor for Academic Affairs and professor of Pediatrics, Pharmacology and Cancer Biology at Duke, will receive the prize on March 31, 2011, when she is scheduled to give a Vanderbilt Discovery Lecture.

"This is our fifth Vanderbilt Prize," said Susan Wente, Ph.D., associate vice chancellor for Research and senior associate dean for Biomedical Sciences at Vanderbilt. "The continued support of this very innovative national prize shows public evidence of the value Vanderbilt places on discovery research, mentoring and women scientists."

Prize winners receive a $25,000 award, and also serve as mentors to women who are pursuing graduate studies in the biomedical sciences at the School of Medicine. This year's student scholar will be selected in early 2011.

Andrews received her Ph.D. in biology from Massachusetts Institute of Technology in 1985, and her M.D. from Harvard Medical School two years later. After completing her residency and fellowship in pediatrics and hematology/oncology at Children's Hospital Boston and the Dana-Farber Cancer Institute, she joined the Harvard faculty in 1991.

Andrews has made major contributions to understanding disorders of mammalian iron homeostasis, including iron deficiency and genetic hemochromatosis.

Before moving to Duke in 2007, she also served as director of the Harvard/MIT M.D.-Ph.D. program and as dean for basic sciences and graduate studies at Harvard Medical School.

Andrews is a member of the Institute of Medicine of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences. She is a former Howard Hughes Medical Institute investigator, and was the 2009 president of the American Society of Clinical Investigation.
-end-
For a list of previous winners and the 2011 nomination form, go to https://medschool.vanderbilt.edu/dean and click on "Vanderbilt Prize."

Vanderbilt University Medical Center

Related Medicine Articles from Brightsurf:

An ultrasonic projector for medicine
A chip-based technology that modulates intensive sound pressure profiles with high resolution opens up new possibilities for ultrasound therapy.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

How dinosaur research can help medicine
The intervertebral discs connect the vertebrae and give the spine its mobility.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.

Read More: Medicine News and Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.